Plain-English translation of NCT06451198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
After you have a stent placed in your heart to open a blocked artery, you need to take blood-thinning medications to prevent clots. This trial is testing whether , a newer blood thinner, works as well as or better than when combined with another medication called . The study will follow participants for one year to see which combination is safest and most effective.
Older adults who receive heart stents have a higher risk of both dangerous blood clots and bleeding complications. Researchers want to know if this medication might offer a better balance—preventing clots while reducing the risk of serious bleeding—compared to the standard treatment.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to take either the new medication combination or the standard medication combination—both involving two pills taken by mouth daily. You'll take your assigned medications for 12 months and attend follow-up appointments (typically at hospital visits or clinic check-ins) so the research team can monitor your heart health, check for any side effects, and make sure the treatment is working. You'll be asked about any bleeding, chest pain, or other symptoms you experience during the year.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China